CytomX Therapeutics (CTMX) EBIT (QoQ) (2014 - 2026)
CytomX Therapeutics (CTMX) EBIT (QoQ) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | CytomX Therapeutics | 590.32 Mn | 243.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.57% |
| Dec 31, 2025 | -77.14% |
| Sep 30, 2025 | -1,126.13% |
| Jun 30, 2025 | -105.68% |
| Mar 31, 2025 | 27.95% |
| Dec 31, 2024 | 330.04% |
| Sep 30, 2024 | 148.64% |
| Jun 30, 2024 | -172.51% |
| Mar 31, 2024 | 2,023.60% |
| Dec 31, 2023 | -119.40% |
| Sep 30, 2023 | 193.28% |
| Jun 30, 2023 | 40.77% |
| Mar 31, 2023 | 40.54% |
| Dec 31, 2022 | 68.00% |
| Sep 30, 2022 | 1.14% |
| Jun 30, 2022 | 6.26% |
| Mar 31, 2022 | 8.14% |
| Dec 31, 2021 | -12.45% |
| Sep 30, 2021 | -16.26% |
| Jun 30, 2021 | -14.09% |